The latest closing stock price for Aptevo Therapeutics as of November 20, 2024 is 0.29.
An investor who bought $1,000 worth of Aptevo Therapeutics stock at the IPO in 2016 would have $-1,000 today, roughly -1 times their original investment - a -70.41% compound annual growth rate over 8 years.
The all-time high Aptevo Therapeutics stock closing price was 4928.00 on July 20, 2016.
The Aptevo Therapeutics 52-week high stock price is 10.80, which is 3624.1% above the current share price.
The Aptevo Therapeutics 52-week low stock price is 0.14, which is 51.7% below the current share price.
The average Aptevo Therapeutics stock price for the last 52 weeks is 2.77.
An investor who bought $1,000 worth of Aptevo Therapeutics stock at the IPO in 2016 would have $-1,000 today, roughly -1 times their original investment - a -70.41% compound annual growth rate over 8 years.
The all-time high Aptevo Therapeutics stock closing price was 4928.00 on July 20, 2016.
The Aptevo Therapeutics 52-week high stock price is 10.80, which is 3624.1% above the current share price.
The Aptevo Therapeutics 52-week low stock price is 0.14, which is 51.7% below the current share price.
The average Aptevo Therapeutics stock price for the last 52 weeks is 2.77.